● Recruiting

A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid Tumors

Condition: Solid Tumors, Adult · Sponsor: Hutchmed

PhasePhase 1/Phase 2

Planned participants147

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a first-in-human (FIH), phase Ⅰ/Ⅱa, open-label, multicenter clinical study of HMPL-A251 monotherapy in adult participants with unresectable, advanced or metastatic HER2-expressing solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Contact details are listed per location below or on the registry record.

Always discuss trial participation with your own doctor first.

Locations (15)

SCRI HealthONE	Denver, Colorado, United States	Recruiting
BRCR Global	Plantation, Florida, United States	Recruiting
Florida Clinical Trials Group LLC (Plantation)	Plantation, Florida, United States	Recruiting
Florida Clinical Trials Group LLC (Tamarac)	Tamarac, Florida, United States	Not Yet Recruiting
START New Jersey	East Brunswick, New Jersey, United States	Not Yet Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Not Yet Recruiting
Cleveland Clinic Taussig Cancer Center	Cleveland, Ohio, United States	Recruiting
Northwest Medical Specialties, PLLC	Tacoma, Washington, United States	Not Yet Recruiting
Peking University First Hospital	Beijing, China	Recruiting
Hunan Cancer Hospital	Changsha, China	Recruiting
Sun Yat-sen University Cancer Center	Guangzhou, China	Recruiting
The First Affiliated Hospital of Anhui Medical University	Hefei, China	Recruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07228247